Business Description

SymBio Pharmaceuticals Ltd

ISIN : US87150Y1001
http://www.symbiopharma.com
5-23-7 Shimbashi, San-Ei Building, 8th Floor, Minato-ku, Tokyo, JPN, 105-0004

Share Class Description:

SYMQY: ADR
Compare
Compare
TSE:4524TSE:4574TSE:4538TSE:4512TSE:4597TSE:4539TSE:4892TSE:4586TSE:4883TSE:4554ZTSXTER:MRKTSE:4502LSE:HLNNSE:SUNPHARMATSE:4523TSE:4507SZSE:000538XSWX:SDZHKSE:03692
Traded in other countries / regions
4582.JapanSYMQY.USA
IPO Date
2015-01-16
Description
SymBio Pharmaceuticals Ltd is a biopharmaceutical company engaged in manufacturing and commercializing drugs for oncology, hematology, and pain management.

Financial Strength

8/10
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.91
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.64
Distress
Grey
Safe
Beneish M-Score -4.42
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

8/10
Name Current Vs Industry Vs History
3-Year Revenue Growth Rate 15.6
3-Year EBITDA Growth Rate 49
3-Year EPS without NRI Growth Rate 33.3
3-Year FCF Growth Rate 56.4
3-Year Book Growth Rate 11.9

Momentum Rank

3/10
Name Current Vs Industry Vs History
6-1 Month Momentum % -58.42
12-1 Month Momentum % -76.5

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 10.68
Quick Ratio 10.43
Cash Ratio 9.16
Days Inventory 126.08
Days Sales Outstanding 74.51
Days Payable 20.84

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -3.4

Profitability Rank

2/10
Name Current Vs Industry Vs History
Gross Margin % 78.38
Operating Margin % -35.96
Net Margin % -59.12
FCF Margin % -9.26
ROE % -35.37
ROA % -31.99
ROIC % -139
ROC (Joel Greenblatt) % -148.71
ROCE % -21.51
Years of Profitability over Past 10-Year 2

GF Value Rank

2/10
Name Current Vs Industry Vs History
PS Ratio 1.42
PB Ratio 1.04
Price-to-Tangible-Book 1.03
EV-to-EBIT -0.52
EV-to-EBITDA -0.52
EV-to-Forward-EBITDA 11.12
EV-to-Revenue 0.19
EV-to-Forward-Revenue 2
EV-to-FCF -2.05
Price-to-Median-PS-Value 0.39
Price-to-Net-Current-Asset-Value 1.05
Price-to-Net-Cash 1.25
Earnings Yield (Greenblatt) % -192.31
FCF Yield % -5.76

Financials

SYMQY's 30-Y Financials
AAPL
Income Statement Breakdown FY
No Enough Data
AAPL
Balance Sheet Breakdown
No Enough Data
AAPL
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:SYMQY

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

SymBio Pharmaceuticals Ltd Executives

Details

GF Value: $2.37

SYMQY

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 32.069
EPS (TTM) ($) -0.459
Beta 0.19
Volatility % 60.46
14-Day RSI 0
14-Day ATR ($) 0.000405
20-Day SMA ($) 1.21
12-1 Month Momentum % -76.5
52-Week Range ($) 1.21 - 5.15
Shares Outstanding (Mil) 45.81

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

SymBio Pharmaceuticals Ltd Filings

Filing Date Document Date Form
No Filing Data

SymBio Pharmaceuticals Ltd Stock Events

Financials Calendars
Event Date Price($)
No Event Data

SymBio Pharmaceuticals Ltd Frequently Asked Questions

What is SymBio Pharmaceuticals Ltd(SYMQY)'s stock price today?
The current price of SYMQY is $1.21. The 52 week high of SYMQY is $5.15 and 52 week low is $1.21.
When is next earnings date of SymBio Pharmaceuticals Ltd(SYMQY)?
The next earnings date of SymBio Pharmaceuticals Ltd(SYMQY) is .
Does SymBio Pharmaceuticals Ltd(SYMQY) pay dividends? If so, how much?
SymBio Pharmaceuticals Ltd(SYMQY) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.